359877-69-3

Upstream product

• 1445-73-4 1-Methyl-4-piperidone 
• 359878-16-3 C₂₄H₂₇F₃N₂O₃*ClH 
• 359878-18-5 1-methyl-N-(4-methylbenzyl)-piperidin-4-amine 
• 4693-91-8 4-methoxyphenyl-acetic chloride 
• 2043-61-0 cyclohexanecarbaldehyde 
• 359878-14-1 N-((4-methylphenyl)methyl)-N-(piperidin-4-yl)-4-methoxyphenylacetamide 
• 359878-15-2 4-(4-methylbenzylamino)-1-(trifluoroacetyl)piperidine 
• 65220-86-2 1-(trifluoroacetyl)-4-piperidone 
• 41979-39-9 4-piperidone hydrochloride 
• 359877-52-4 tert-butyl 4-((4-methylphenyl)methyl)aminopiperidine carboxylate 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 104-84-7 para-methylbenzylamine 

Downstream Products

• 359878-20-9 2-(4-methoxyphenyl)-N-(4-methylbenzyl)-N-(1-cyclohexylmethylpiperidin-4-yl) acetamide hydrochloride 

Relevant academic research and scientific papers

AZACYCLIC COMPOUNDS

Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.

USE OF 4-AMINO-PIPERIDINES FOR TREATING SLEEP DISORDERS

Inverse agonists and antagonists of serotonin receptors are disclosed for use in treating sleep disorders such as insomnia, and specifically sleep maintenance insomnia. The compound increase slow wave sleep, decrease the number of awakenings after sleep onset, and decrease the time awake after sleep onset.

Azacyclic compounds

Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.